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ABSTRACT
The collaborative effort of an international research team 
from the Early Career Psychiatrists section of the World 
Psychiatry Association has brought about an easy- to- use, 
quick and stepwise mental health care toolkit for the 
identification and appropriate referral of those in need of 
mental health care during the pandemic. This simple guide 
can be applied in the general outpatient setting and is 
catered for all healthcare professionals, regardless of their 
expertise within the mental health field with minimal training. 
It is our hope that by incorporating this toolkit into our daily 
clinical care during the pandemic for high- risk patients and 
patients with non- specific complaints, we will be able to 
bridge the mental health gap present in our society.
INTRODUCTION
Following recent infectious disease outbreaks 
both at national (epidemic) and global levels 
(pandemic), there has been an increased 
preparedness by most countries against future 
outbreaks with a focus mainly on rapid case 
isolation, quarantine, vaccine, antiviral treat-
ment and economic preparedness. However, 
little attention has been given to the acute 
and long- term mental health impact of such 
events.1 2
In the current COVID-19 pandemic, there 
had been minimal mental health planning 
in advance of the pandemic, nor following 
the identification of the first cases in several 
countries such as India, Lebanon, as well as 
Nigeria. Despite research done following 
the Ebola outbreak in Nigeria in 2014 that 
pointed out an increased prevalence of 
psychological distress in survivors and rela-
tive(s) of those infected by the Ebola Virus, 
mental health planning and preparedness 
was not included in the COVID-19 prepared-
ness plan.3 4 As a result, COVID-19 found 
most countries unprepared for the increased 
demand in mental health care brought by the 
pandemic.
Further to the development of a guiding 
framework for the implementation and evalu-
ation of mental health care needs during the 
COVID-19 pandemic,5 we set out to prepare 
a stepped care toolkit by which the mental 
health challenges of different countries could 
be planned ahead irrespective of what phase 
of the pandemic they were in. Preventing 
and planning an integrated and multi- step 
approach through which the specific mental 
health challenges for each country, including 
the management of alcohol, substance use 
and behavioural addiction, could be prop-
erly addressed is fundamental as well as the 
development of alternative therapeutic and 
rehabilitative tools and a wider application 
and development of telepsychiatric means, 
particularly in those countries with already 
established service.6 Addressing COVID-19–
related stigma in such a framework is crucial, 
as stigma towards the infection, spread via 
misinformation and myths in mainstream 
and social media outlets, was also identified as 
a major factor implicated in the extent of the 
spread of the pandemic. This goes in concor-
dance with lessons learnt from past infectious 
disease outbreaks.7 All the aforementioned 
primary mental health targets during the 
pandemic were the products of the collabo-
rative effort of the Early Career Psychiatrist–
World Psychiatric Association (ECP- WPA) 
research group. The research team held 
meetings via video conferencing and deliber-
ated on the numerous gaps in mental health 
care during the pandemic from their coun-
try’s perspectives and proposed strategies and 
interventions to bridge these gaps.
The collaborative effort of this research 
team has also brought about an easy- to- use, 
quick and stepwise mental health care 
toolkit for the identification and appropriate 
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referral of those in need of mental health care during 
the pandemic (box 1). This simple guide can be applied 
in the general outpatient setting and is catered for all 
healthcare professionals, regardless of their expertise 
within the mental health field. It is our hope that by incor-
porating this guide into our daily clinical care during the 
pandemic, we will be able to bridge the mental health gap 
present in our society.
Rationale for stepped care mental health toolkit
During pandemics, mental health services are often inad-
equate and insufficient. Redeployment of mental health 
professionals to frontline healthcare workers also adds to 
the decreased mental health human resources that are 
available.8 Low- income and middle- income countries 
(LMICs) with already inadequate mental health services 
are faced with the increase in prevalence of psychosocial 
distress in the general population and the worsening of 
the mental health gap already present.9–11 With insuffi-
cient number of qualified mental health providers and 
significant disparity in mental health services between 
urban and rural settings, there will be an increased 
dependence on primary healthcare as well as telemedi-
cine services for accessing mental healthcare.12 There is, 
thus the need of a stepped care approach using a mental 
health toolkit that highlights the most prevalent psycho-
social problems during the current COVID-19 pandemic 
(from reviewed literature) which could aid in bridging 
the mental health gap in LMIC as well as improve 
mental health service delivery in high- income countries 
by providing mental health services at the primary and 
community healthcare levels with appropriate referral to 
specialised mental health facilities as needed.
Training of healthcare workers
In order to achieve reliable screening results, healthcare 
workers at the primary healthcare and community health-
care levels would require some form of training on the 
use of the psychometric tools by mental health profes-
sionals (psychiatrists, clinical psychologist or psychiatric 
nurses) using face- to- face or telecommunications means 
(to maintain physical distancing required during this 
pandemic). It has been shown that with as little as 3 hours 
of training on the use of psychometric tools, inter- rater 
reliability of up to 81% can be achieved.13 These train-
ings can be reinforced periodically using pre- recorded 
training videos. All psychometric tools used in this toolkit 
have been validated in different countries and in different 
settings including primary care settings.
Sampling of at-risk groups
During infectious disease outbreaks and pandemics, the 
at- risk populations (group of individuals most susceptible 
to the infection during the outbreak14) are at increased 
risk of the infectious disease and also of the psychosocial 
consequences associated with the infectious disease. The 
at- risk populations often become hard to reach due to 
stigma, and physical and social distancing (which could be 
Box 1 COVID-19 mental health care toolkit
STEP I
Identification of at- risk groups for mental health disorders during the 
different phases of the pandemic, bearing in mind the emotional ep-
idemic curve as proposed by the ECP research group.5 Sensitisation 
and recruitment of patients for screening can be carried out using the 
previously suggested methods. In settings where a database of service 
users already exists, this can be used to identify and screen at- risk 
populations.
1. Persons under quarantine.
2. Family members/relatives/close contacts potentially at high risk for 
COVID-19 infection.
3. Persons who have tested positive for COVID-19 (asymptomatic and 
symptomatic).
4. Frontline healthcare workers.
5. Persons who lost family and friends secondary COVID-19 infection.
6. Persons who contact mental health services, such as telepsychiatry 
helplines and services.
7. Vulnerable groups such as the elderly, those at risk of intimate 
partner violence, as well as Lesbian, Gay, Bisexual and Transsexual 
(LGBT) and other social minorities.
8. People presenting to primary care settings with non- specific 
complaints.
STEP II
Screen for Mental Health Distress (MHD) using the General Health 
Questionnaire—1220 (GHQ-12) in the most convenient language of the 
person receiving the screening. This can be done through telemedicine, 
online screening surveys, emergency care settings, primary and com-
munity healthcare settings.
1. Negative screen (GHQ score less than 4): Counsel and educate on 
preventing mental illness and promoting good mental health us-
ing the WHO guidelines,21 as well as reducing stigma related to 
COVID-19. For high- risk groups, proceed to step 3 despite negative 
screening.
2. Positive screen (GHQ score greater than or equal to 4): Provide list of 
options to person receiving the screening.
i. Explain the process following a positive screen.
ii. Explain the possibility of loss of anonymity for persons being 
screened through telemedicine means (breach of confidentiality) 
should severe mental health challenges be discovered on fur-
ther screening as such cases would be scaled up for appropriate 
treatment.
iii. Request informed consent to proceed.
iv. Proceed to step 3 for application of quick screen toolkit* as as-
sembled by the ECP research group.
STEP III
The quick screen toolkit consists of seven screening instruments which 
can be used for screening and severity rating of common mental disor-
ders at the primary care level. A positive screen using any of the tools 
moves person assessing care to STEP IV. Any positive screen with a 
moderate or severe rating will be referred for face- to- face specialist 
psychiatric consultation only. The screening should take approximately 
15–20 min.
1. Patient Health Questionnaire22 (PHQ) 9 for the screening of major 
depression.
2. Coronavirus Anxiety Scale23 (CAS) for the screening of COVID-19–
related anxiety.
3. Abbreviated PTSD checklist—civilian version24 (PCL- C) for the 
screening of post- traumatic stress disorder.
Continued
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the measures put in place to mitigate the spread of infec-
tion). Thus, the at- risk groups become hidden and hard 
to reach.15 Following a review of the literature published 
during the COVID-19 outbreak, we were able to identify 
the at- risk groups as listed in Box 1 16 17 18 19 . These at- risk 
groups as well as members of the general population (with 
non- specific psychological complaints such as insomnia 
and somatising complaints) presenting at general outpa-
tient clinics and community health centres during the 
pandemic should be screened for mental health distress 
using the General Health Questionnaire-12 (GHQ-12). 
We advise the use of flyers, posters and announcements on 
mainstream and social media on the availability of psycho-
social services at the community and primary healthcare 
level to aid in the recruitment of patients for screening. 
These recruitment strategies should avoid the use of stig-
matising languages and should be communicated in such 
a way to encourage patient turn- up. Community health 
workers should build rapport with potential patients in 
the community to encourage their use of available mental 
health services at health centres. These service users are 
further encouraged to spread the word on the availability 
of psychosocial services in their locality.
Benefits of toolkit
Evaluation of this toolkit can provide evidence for 
research approaches to community health programmes, 
to discover what works and why, as well as barriers and 
outcomes. The use of this toolkit cuts down on the time 
required for mental health care to reach large popula-
tions at times of pandemic as well as those in hard- to- 
reach areas, for example, rural areas. Data collected from 
use of this toolkit could serve as evidence for the mental 
health impact of pandemics on different populations and 
high- risk individuals, allowing for development of mental 
health strategies in future pandemic preparedness.
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Box 1 Continued
4. Alcohol Use Disorder Identification Test25 (AUDIT) for the screening 
of alcohol misuse.
5. Drug Abuse Screening Test26 (DAST) 10 for the screening of psycho-
active substance abuse.
6. Columbia Suicide Severity Rating Scale27 (C- SSRS) for the screening 
of suicidality.
7. Global Assessment of Functioning28 (GAF) scale to assess the need 
for in- patient care.
STEP IV
Upscale the person seeking care to the appropriate sector for manage-
ment depending on the severity of the quick screen toolkit. The man-
agement involves:
1. Psychological counselling by trained counsellors if available in par-
ticular settings for positive screens with mild severity rating (except 
mild rating on the C- SSRS where minimal referral is for psycholog-
ical therapy).
2. Psychological therapy—this could be through telepsychiatry means 
using video- conferencing or face- to- face consultation depending on 
the phase of the COVID-19 pandemic.
3. Psychiatric outpatient consultation for severity ratings greater than 
mild.
4. Psychiatric inpatient care for severity rating greater than moderate.
5. All persons seeking care are to be entered into a data system to 
enable to adequate follow- up. During each follow- up, a phone call 
is put across and person is screen to determine severity rating us-
ing previously used tool for which they screened positive. These are 
done on a weekly basis.
6. All data should be stored with the person’s identification number, not 
with their name nor other identifiable information.
*Some content of the quick screen toolkit was adapted from The SAMHSA- 
HRSA (Substance Abuse and Mental Health Services Administration and the 
Health Resources and Services Administration) Center for Integrated Health 
Solutions (CIHS) and all tools have not been validated to e- mental health use.
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